<!DOCTYPE html>
<html>
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
		<html lang="ru">
		<meta name="Национальный научный центр фармаконадзора - сообщить о нежелательной или побочной реакции на лекарственный препарат" content="">
		<meta name="apple-mobile-web-app-capable" content="yes">
		<meta name="viewport" content="width=device-width, initial-scale=1">
		<title>Национальный научный центр фармаконадзора - сообщить о нежелательной или побочной реакции на лекарственный препарат</title>
		<meta name=description content="В национальном научном центре фармаконадзора вы можете сообщить о нежелательной или побочной реакции на лекарственный препарат и получить консультацию в области лекарственной безопасности">
		<meta name=news_keywords content="заявка, нежелательная реакция, препарат, лекарство, лекарственная безопасность, побочная реакция">
		<meta name=keywords content="заявка, нежелательная реакция, препарат, лекарство, лекарственная безопасность, побочная реакция">
		<link rel="shortcut icon" href="/favicon.ico" type="image/x-icon">
		<link rel="icon" href="/favicon.ico" type="image/x-icon">
		<meta http-equiv="X-UA-Compatible" content="IE=edge">
		<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
		<meta name="format-detection" content="telephone=no">
		<script src="js/jquery-1.11.2.min.js"></script>
		<script src="libs/bootstrap/js/bootstrap.js"></script>
		<script src="js/jquery.magnific-popup.min.js"></script>
		<script src="js/jquery-ui.js"></script>
		<script src="js/common.js"></script>	
		<link rel="stylesheet" href="libs/bootstrap/css/bootstrap-grid.min.css">
		<link rel="stylesheet" href="libs/bootstrap/css/bootstrap.css">
		<link rel="stylesheet" href="libs/bootstrap/css/bootstrap-theme.css">
		<link rel="stylesheet" type="text/css" href="/css/magnific-popup.css"/>
		<link rel="stylesheet" href="//code.jquery.com/ui/1.12.1/themes/base/jquery-ui.css">
		<link rel="stylesheet" href="css/main.css">		
		<link rel="stylesheet" href="css/media.css">
		<link rel="stylesheet" href="css/admika.css">		
		<link href="https://fonts.googleapis.com/css?family=Roboto+Condensed:400,700&amp;subset=cyrillic,cyrillic-ext" rel="stylesheet">
		<link href="https://fonts.googleapis.com/css?family=Roboto:400,700&amp;subset=cyrillic,cyrillic-ext" rel="stylesheet">
		<script src="/js/admika.js"></script>
<meta name="yandex-verification" content="1574edd466a1fa79" />	

	</head>
	<body>
		<!--Header-->
		<header>
			<div class="container">
				<div class="row">
					<div id="fn-header">
						<div class="col-lg-4 col-md-4 col-sm-4 col-xs-12">
							<div id="fn-logo">
								<img src="/images/logo.png" alt="">
							</div>
						</div>
						<div class="col-lg-4 col-md-4 col-sm-4 col-xs-12">
							<div id="fn-headertel">
								<span>8 800 2000333</span>
								<p>Круглосуточно. Бесплатно по России</p>
								<div class="tel-button-wrap">
									<a href="#tel-modal" data-toggle="modal" class="tel-button">Войти</a>
								</div>
							</div>
						</div>
						<div class="col-lg-4 col-md-4 col-sm-4 col-xs-12 call">
							<div id="fn-headercall" class="clearfix">
								<div class="headercall-button">
									<a href="#hidden_form" class="popup_form"><img src="/images/megafon.png"><span>Сообщить <br>
									о нежелательной реакции</span></a>
								</div>
							</div>
							<style>
								.socials{margin-top:15px;text-align:right}
								.socials div{width:42px;height:42px;margin-left:15px;display:inline-block}
								.socials img{width:42px;height:42px;}
								.socials-bottom{margin-top:15px;text-align:left}
								.socials-bottom div{width:42px;height:42px;margin-left:15px;display:inline-block}
								.socials-bottom img{width:42px;height:42px;}
							</style>
							<div class='socials'>
								<div><a href="https://api.whatsapp.com/send?phone=+79037992186&text=Сообщение о нежелательной реакции"><img src=/images/whatsapp.png alt="whatsapp icon"></a></div>
								<div><a href="viber://chat?number=+79037992186"><img src=/images/viber.png alt="viber icon"></a></div>
								<div><a href="tg://msg?text=Сообщение о нежелательной реакции&to=+79037992186"><img src=/images/telegram.png alt="telegrtam icon"></a></div>
							</div>
							<div class='socials' style="text-align: center;">
								<div>+7(903)7992186</div>
							</div>
						</div>
					</div>
				</div>
			</div>
			<hr />
		</header>
		<!--EndHeader-->
		<!--Menu-->
		<section id="fn-topmenu">
			<nav role="navigation" class="navbar navbar-default">
				<div class="container">
					<div class="row">
						<div class="col-lg-12">
							<div class="navbar-header">
								<button type="button" data-target="#navbarCollapse" data-toggle="collapse" class="navbar-toggle">
									<span class="sr-only">Toggle navigation</span>
									<span class="icon-bar"></span>
									<span class="icon-bar"></span>
									<span class="icon-bar"></span>
								</button>
		 					</div>
							<div id="navbarCollapse" class="collapse navbar-collapse">
								<ul class="nav navbar-nav">
									<li class="active"><a>Главная</a></li>
									<li><a href="/about">О нас</a></li>
									<li class="dropdown">
	 									<a data-toggle="dropdown" class="dropdown-toggle" href="#">Информация</a>
										<ul role="menu" class="dropdown-menu">
											<li><a href="/statistika">Статистика</a></li>
											<li><a>Ресурсы</a></li>
										</ul>
									</li>
									<li class="dropdown">
	 									<a data-toggle="dropdown" class="dropdown-toggle" href="#">Услуги ФН</a>
										<ul role="menu" class="dropdown-menu">
											<li><a href="/struktura_fn">Структура ФН</a></li>
											<li><a>База данных</a></li>
										</ul>
									</li>
									<li><a href="/contacts">Контакты</a></li>
									<li class="dropdown">
	 									<a data-toggle="dropdown" class="dropdown-toggle" href="#">Статьи</a>
										<ul role="menu" class="dropdown-menu">
											<li><a href="/drug_safety">Лекарственная безопасность</a></li>
										</ul>
									</li>
								</ul>
							</div>
						</div>
					</div>
				</div>
			</nav>
		</section>

		<!--Presentation-->		
		<section id="presentation">
			<div class="container">
				<div class="row">
					<div class="col-lg-12">
						<div class="slide">							
							<span class="first-slide-top">New legislative requirements to the pharmacovigilance system of<br> the holder of the registration certificate in the Russian Federation</span>
							<span class="first-slide-bottom">Possibilities of pharmacovigilance<br>outsourcing system </span>
						</div>
						<div class="slide-2 slide">							
							<div class="slide-two-header clearfix">
								<h2>MONITORING OF DRUG SAFETY</h2>
								<hr />
							</div>
							<div class="slide-two-center clearfix">
								<div class="citata">
									<span>Pharmacovigilance</span>								
								</div>
								<p>Pharmacological science and practical activities  are relating to the <i>collection, detection, assessment, monitoring, and prevention</i> of adverse effects  with drugs</p>
							</div>	
							<div class="slide-two-bottom">
							<p>Medical products that are in circulation in the Russian Federation shall be monitored of the security in order to detect the possible negative consequences, warning patients and their protection against the use of such drugs.</p>
							<span>(Federal Law No. 61-FZ of 12.04.2010 "On the circulation of medicinal products" article 64).</span>
							</div>						
						</div>		
						<div class="slide-3 slide">							
							<div class="slide-three-header">
								<h2>REGULATORY AND LEGAL FRAMEWORK OF PHARMACOVIGILANCE</h2>	
							</div>
							<div class="pres-text-block2">
								<ul>
									<li><img src="images/triangle-alpha-green.png"><span>Federal Law No. 61-FZ of 12.04.2010 "On the circulation of medicinal products“</span></li>
									<li><img src="images/triangle-alpha-green.png"><span>The letter of Federal Service for Surveillance in Healthcare 14.06.2017 N-1420/17 "On the new legislative requirements for pharmacovigilance“;</span></li>
									<li><img src="images/triangle-alpha-green.png"><span>Order of  Federal Service for Surveillance in Healthcare No. 1071 of 15.02.2017 "On approval of the procedure for the implementation of pharmacovigilance” </span></li>
									<li><img src="images/triangle-alpha-green.png"><span>Guideline on good pharmacovigilance practices (GVP) of the Eurasian Economic Union, approved by the Council of the Eurasian Economic Commission 03.11.2016 2016 №87</span></li>
									<li><img src="images/triangle-alpha-green.png"><span>Good Clinical Practice (GCP), approved by the Council of ECE 03.11.2016 2016 No. 79</span></li>
									<li><img src="images/triangle-alpha-green.png"><span>Russian Ministry of Health order from 07.09.2015 N 5539 "On approval of a sample implementation of quality control of drugs for medical use“</span></li>
									<li><img src="images/triangle-alpha-green.png"><span>Ministry of Health and Social Development order  of the Russian Federation of 26.08.2010 N 758n "On Approving the Procedure for Suspending the Use of a Medicinal Product for Medical Use« (Russian Ministry of Justice registered 31.08.2010 N 18325)</span></li>
									<li><img src="images/triangle-alpha-green.png"><span>Russian Ministry of Health order of 26.08.2010 N 749n "On approval of the form of the documents containing the results of safety monitoring of the medicinal products for medical use with the aim of confirming its state of the  registration"</span></li>
									<li><img src="images/triangle-alpha-green.png"><span>Russian Ministry of Health order of 07.09.2016 №682n "On approval of the form of the documents containing the results of monitoring the efficacy and safety of the medicinal product for the medical use conducted by the holder or by the owner of the registration certificate of a medical or deprived legal entity"</span></li>
									<li><span>National standard "Appropriate Clinical Practice. GOST R 52379-2005 ", approved by the order of Russian technical regulation system from 27.09.2005 N 232-s.</span></li>
								</ul>
							</div>
						</div>
						<div class="slide-4 slide">							
							<div class="slide-three-header">
								<h2>REGULATORY MEASURES IN THE IDENTIFICATION OF SAFETY PROBLEMS OF DRUGS</h2>	
							</div>
							<div class="pres-text-block2">
								<ul>
									<li><img src="images/triangle-b-w.png"><span>Cancelling of the registration (Art. 32 of the Federal Law №61)</span></li>
									<li><img src="images/triangle-b-w.png"><span>Suspension of medical products circulation (Art. 65 of the Federal Law №61)</span></li>
									<li><img src="images/triangle-b-w.png"><span>Administrative punishment (Art. 68 of the Federal Law №61)</span></li>
									<li><img src="images/triangle-b-w.png"><span>Criminal Code of the Russian Federation, Article 238 “ Production, storage, transportation or sale of goods and products, perfomance of the works or services, not meeting safety requirements)</span></li>
									<li><img src="images/triangle-b-w.png"><span>Changes to the medical instruction (order of Federal Service for Surveillance in Healthcare №1071 from 15.02.2017)</span></li>
									<li><img src="images/triangle-b-w.png"><span>Changes to the Protocol of medical trials (Art. 40 of the Federal Law №61)</span></li>
									<li><img src="images/triangle-b-w.png"><span>Suspension, delay of medical trials (Art. 40 of the Federal Law №61)</span></li>
									<li><img src="images/triangle-b-w.png"><span>Request for Risk Management Plan  (RMP) </span></li>
									<li><img src="images/triangle-b-w.png"><span>Additional monitoring drug safety (ЕАЭС GVP)</span></li>
								</ul>
							</div>
						</div>
						<div class="slide-5 slide">							
							<div class="slide-five-header">
								<img src="images/logo.png">
								<h2>ADDITIONAL REGULATORY REQUIREMENTS OF  OF THE EURASIAN ECONOMIC UNION</h2>	
							</div>
							<div class="pres-text-block2">
								<ol>
									<li><span>Harmonisation of the pharmacovigilance system Russian Federation with GVP, GCP of the Eurasian Economic Union and EU GVP;</span></li>
									<li><span>The obligation to provide the Master file by request from Federal Service for Surveillance in Healthcare;</span></li>
									<li><span>The requirement for the presence of the Pharmacovigilance Officer on Eurasian Economic Union;</span></li>
									<li><span>Requirements for screening local scientific literature;</span></li>
									<li><span>Possible laboratory control of drugs if we got adverse reactions in sample test;</span></li>
									<li><span>Requirements to training local staff on pharmacovigilance;</span></li>
									<li><span>Possible to request RMP  of registered drugs before implementation of risk management measures;</span></li>
									<li><span>Requirements to create risk management programs considering specific Federal Service for Surveillance in Healthcare </span></li>
									<li><span>Impossibility of copying European PSUR</span></li>
									<li><span>Informing regulators by holders of registration certificates about important changes to the pharmacovigilance system;</span></li>
									<li><span>Planned and extraordinary inspection pharmacovigilance system;</span></li>
									<li><span>The appointment of post-marketing clinical trials;</span></li>
									<li><span>Requirements for informing doctors and consumers about the new data safety of drugs</span></li>
								</ul>
							</div>
						</div>
						<div class="slide-6 slide">							
							<div class="pres-text-block">
								<strong>INDEPENDENT CREATION OF THE PHARMACOVIGILANCE SYSTEM</strong>							
								<ul>
									<li><span>Prepare a master file of the pharmacovigilance system;</span></li>
									<li><span>Appoint the Pharmacovigilance Officer  and notify the Federal Service for Surveillance in Healthcare.</span></li>						
									<li><span>Educate Pharmacovigilance Officer and all employees;</span></li>
									<li><span>Create standard operating procedures (SOP) for the main pharmacovigilance processes based on the company's quality management system</span></li>
									<li><span>Ensure the implementation of the SOP, leaving a documentary trace</span></li>
									<li><span>To provide a continuous and qualitative analysis of the balance of benefits and risks of drugs</span></li>
									<li><span>Organize the work of an electronic database of  adverse drug reaction</span></li>
									<li><span>Organize the collection, analysis and evaluation of adverse drug reaction's data</span></li>
									<li><span>Screening scientific literature</span></li>
									<li><span>Prepare periodic security reports in a new format (PRBER)</span></li>
									<li><span>Self-detection and Safety Signal Processing of medicines</span></li>
									<li><span>Independent development of the risk management strategy and risk management plans of the medicines</span></li>
									<li><span>Ensure full and timely submission of responses to regulatory requests</span></li>
									<li><span>Providing regular audits (self-testing)</span></li>
									<li><span>Preparation for inspections of regulatory bodies and inspections commissions (external audits - since 2017)</span></li>
								</ul>
							</div>
							<div class="row">
								<div class="col-lg-3 col-md-3 col-sm-3">								
									<img src="images/man-big.png" class="man">
								</div>
								<div class="col-lg-9 col-md-9 col-sm-9 col-xs-12">
									<div class="risks">										
										<ul>
											<li><span>* NO EXPERIENCE, QUALIFICATIONS OF SPECIALISTS</span></li>
											<li><span>* DEFICITE OF STAFF</span></li>
											<li><span>* 1 OR 2 BRAND IN THE PRODUCT PRODUCTION PORTFOLIO</span></li>
											<li><span>* REQUIREMENTS FOR SAFETY AND EFFICIENCY ASSESSMENT</span></li>
											<li><span>* AVAILABILITY OF SOFTWARE FOR EVALUATION BENEFIT / RISK</span></li>
											<li><span>* HUGE AMOUNT OF ORGANIZATIONAL WORK AND DOCUMENTATION</span></li>
											<li><span>* NECESSITY OF THE USE OF ADDITIONALLY CHARGED RESOURCES OF THE INFORMATION</span></li>
										</ul>
									</div>
								</div>
							</div>
						</div>
						<div class="slide slide-7">
							<strong>SERVICES ANO "NATIONAL SCIENTIFIC CENTER OF PHARMACOVIGILANCE"</strong>
							<table>
								<tr class="td-dark">									
									<td>Title</td>
								</tr>
								<tr class="td-light">								
									<td>Creation and maintenance of documentation of the pharmacovigilance (Master file, SOPs, instructions, positions, etc.)</td>
								</tr>
								<tr class="td-middle">								
									<td>Appointment of a qualified Pharmacovigilance Officer</td>
								</tr>
								<tr class="td-light">									
									<td>Call center organization 24 hours for receiving reports of adverse reaction</td>
								</tr>
								<tr class="td-middle">									
									<td>Organization of the collection of reports about adverse reaction and ineffective drugs by using free and paid scientific data bases of  Russia and The Eurasian economic Union</td>
								</tr>
								<tr class="td-light">									
									<td>Analysis, evaluation and storage of the all reports of adverse reaction , organization of an electronic automated system for recording, processing, storing information about drugs safety</td>
								</tr>
								<tr class="td-middle">									
									<td>Organization of an operative collection of additional information about the adverse reaction in the event of a serious adverse reaction</td>
								</tr>
								<tr class="td-light">									
									<td>Scientific assessment, assessment of the benefit / risk of using an automated system, including routine and 200 additional indicators</td>
								</tr>
								<tr class="td-middle">									
									<td>Preparing, writing of  periodic safety update report (PSUR, PBRER)</td>
								</tr>
								<tr class="td-light">									
									<td>Preparing and evaluation of the risk management system; the risk management planning (RMP)</td>
								</tr>
								<tr class="td-middle">									
									<td>Creating and сonducting  of trainings staff</td>
								</tr>
								<tr class="td-light">									
									<td>Preparing to audits and inspections of Federal Service for Surveillance in Healthcare</td>
								</tr>
								<tr class="td-middle">									
									<td>Organization of the ensuring system of the healthcare stuff and patients by informing about the safety of drugs</td>
								</tr>
								<tr class="td-light">									
									<td>Implementation of obligations to the authorized bodies of the member states of the Eurasian Union in terms of collecting information on side effects, filing periodic reports, providing responses to requests</td>
								</tr>
							</table>							
						</div>	
						<div class="slide slide-8">
							<strong>FORMAT OF COOPERATION - THE CONCLUSION OF THE OUTSOURCING CONTRACT</strong>
							<div class="row">
								<div class="col-lg-12 col-xs-12">
									<img src="images/slide-8.png">							
								</div>
							</div>
						</div>
						<div class="slide slide-9 custom">
							<img src="images/slide-9.png">
							<strong>ICSR ASSESSMENT (STANDARD VS. NRSP METHODS)</strong>
							<div class="slide-9-middle">
								<div class="slide-9-left">
									<p><strong>Patient`s info</strong> (except those indicated in yellow card: age in days, months and years, diagnosis in ICD 10 codes, age categories and self-treatment cases)
									ADR info (duration, leading clinical manifestations, type according to WHO, Rawlins-Thompson, Will-Brawn, DoTS; severity according to Karch-Lasagna, LDS, Hartwig-Siegel and CTCAE, preventability according to Hallas, Granada test and Schumock-Tornton, MedDRA codes)
									</p>
									<p><strong>Suspected drug`s info</strong> (duration of therapy before ADR, ATC codes, presence in local formularies and recommendations, State Register of Medicinal Products, List of Life-Saving and Necessary Medicinal Products)</p>
									<p><strong>Info about other (concomitant) drugs</strong> (ATC codes, Causality assessment according to Horn-Hansten, interaction checker)</p>
									<p><strong>Reporter`s info</strong> (info about medical organization and WHO criteria for it)</p>
									<p><strong>Causality assessment</strong> (Naranjo and Karch-Lasagna methods)</p>
									<p><strong>Integral method</strong> – assessment of drug related problems (DRP, incl. local modification)</p>
									<p><strong>Agreement analysis</strong> for methods (during assessment of severity and preventability) and for experts</p>
									<p><strong>Search and evaluation of “Off Label” prescriptions</strong> (age restrictions, ignoring of contraindications, dosing, frequency and duration of therapy)</p>
								</div>
								<div class="slide-9-right">
									<p><strong>Patient`s info</strong> (gender, age, pregnancy/lactation, consequences, clinical diagnosis, allergy anamnesis, hospital stay and domestic use of medications)</p>
									<p><strong>ADR info</strong> (dates of beginning and finishing, description, categories, seriousness)</p>
									<p><strong>Suspected drug`s info</strong> (trade name, INN, manufacturer and MAH, indications, single dose, frequency,  route of introduction, batch/lot number, start date for therapy and date of its end)</p>
									<p><strong>Info about other (concomitant) drugs</strong> (trade name, INN, dosing, routes of introduction and duration of therapy)</p>
									<p><strong>Information about correction</strong></p>
									<p><strong>Reporter`s info</strong> (name, position, date of form filling)</p>
									<p><strong>Causality assessment performed by doctor</strong> (if any)</p>
								</div>
							</div>							
						</div>
						<div class="slide slide-10">
							<strong>EXAMPLES OF DATABASE RESULTS (ADR TYPES)</strong>
							<div class="row">
								<div class="col-lg-5 col-md-5 col-sm-6 col-xs-12">									
									<img src="images/slide-10-left.png">
								</div>
								<div class="col-lg-6 col-md-6 col-sm-6 col-xs-12">
									<img src="images/slide-10-right.png">
								</div>
							</div>
							<span>We use WHO, Rawlins-Thompson, Will-Brawn and DoTS classifications</span>						
						</div>	
						<div class="slide slide-11">
							<strong>EXAMPLES OF DATABASE RESULTS (ATC GROUPS)</strong>
							<div class="row">
								<div class="col-lg-6 col-md-6 col-sm-6 col-xs-12">
									<img src="images/slide-11.png">
								</div>
								<div class="col-lg-6 col-md-6 col-sm-6 col-xs-12">
									<span>We can perform analysis in different groups, incl. all levels of ATC classification </span>
								</div>
							</div>												
						</div>		
						<div class="slide slide-12">
							<strong>EXAMPLES OF DATABASE RESULTS</strong>
							<div class="row">
								<div class="col-lg-10">
									<img src="images/slide-12.png">
								</div>								
							</div>												
						</div>
						<div class="slide slide-13">
							<strong>EXAMPLES OF DATABASE RESULTS (SEVERITY ASSESSMENT)</strong>
							<div class="row">
								<div class="col-lg-6 col-md-6 col-sm-6 col-xs-12">
									<p>LDS points</p>
									<img src="images/slide-13-left.png">
								</div>
								<div class="col-lg-6 col-md-6 col-sm-6 col-xs-12">
									<img src="images/slide-13-right.png">
								</div>
							</div>
							<span>NCI – CTCAE 4.03 is also available</span>						
						</div>
						<div class="slide slide-14">
							<strong>EXAMPLES OF DATABASE RESULTS (CAUSALITY ASSESSMENT)</strong>
							<div class="row">
								<div class="col-lg-11">
									<img src="images/slide-14.png">
								</div>	
								<span>For causality assessment we use integrated Naranjo, Karch-Lasagna and Horn-Hansten algorithms (RUCAM, ALDEN are used when necessary; Koh, Kramer, Bigaud, Jones and others on request)</span>							
							</div>												
						</div>	
						<div class="slide slide-15">
							<strong>EXAMPLES OF DATABASE RESULTS (PREVENTABILITY ASSESSMENT)</strong>
							<div class="row">
								<div class="col-lg-11">
									<img src="images/slide-15.png">
								</div>														
							</div>												
						</div>										
						<div class="slide slide-16">							
							<h2>WELCOME FOR COLLABORATION</h2>
							<div class="slide-16-block">
								<a href="http://WWW.DRUGSAFETY.RU" class="link-site">WWW.DRUGSAFETY.RU</a>
								<a href="mailto:INFO@DRUGSAFETY.RU" class="link-email">INFO@DRUGSAFETY.RU</a>
								<span>8 800 7778604</span>
								<span>+7(495)799-2186</span>
							</div>
						</div>					
					</div>
				</div>
			</div>
		</section>

		<!--Footer-->
		<footer id="fn-footer">
			<hr />
			<div class="container">
<div class='socials-bottom'>
								<div><a href="https://api.whatsapp.com/send?phone=+79037992186&text=Сообщение о нежелательной реакции"><img src=/images/whatsapp.png alt="whatsapp icon"></a></div>
								<div><a href="viber://chat?number=+79037992186"><img src=/images/viber.png alt="viber icon"></a></div>
								<div><a href="tg://msg?text=Сообщение о нежелательной реакции&to=+79037992186"><img src=/images/telegram.png alt="telegrtam icon"></a></div>
							</div>
		<div class="row">
				<div class="col-lg-12 col-md-12">
					<div class="footercontacts">
						<div class="row">
							<div class="col-lg-4 col-md-4 col-sm-6">
								<div class="footercontact footercontact-office clearfix">
									<h5>Офис</h5>									
									<span>
Москва<br/>Малая Сухаревская площадь<br />д.2,корп.2.
</span>										
								</div>
							</div>
							<div class="col-lg-4 col-md-4 col-sm-6">
								<div class="footercontact footercontact-phone clearfix">
									<h5>Телефон</h5>									
									<strong>+7(495)799-2186</strong></span>									
								</div>
							</div>
							<div class="col-lg-4 col-md-4 col-sm-6">
								<div class="footercontact footercontact-email clearfix">
									<h5>E-mail</h5>									
									<a href="mailto:info@drugsafety.ru">info@drugsafety.ru</a>
								</div>
							</div>							
						</div>
					</div>
				</div>				
			</div>
			<div class="row">
				<div class="col-lg-12 col-xs-12 footertext">
					<span>© 2017 Фармаконадзор<br>Все права защищены</span>
				</div>
		</div>
			</div>
		</footer>
		<!--EndFooter-->
		<div class="hidden">
			<form id="hidden_form" action="/main_form">
				<div>
					<input type="checkbox" name="disclaim"><p>Нажимая кнопку продолжить, вы даете согласие на обработку своих персональных данных</p>
				</div>
				<div class="butt-dis">
					<a href="/main_form" id="block" class="disabled">Продолжить</a>
				</div>
				</div>
			</form>
		</div>
		<div class="modal" id="tel-modal">
			<div class="modal-dialog"> 
	  			<div class="modal-header">	  				
	    			<button class="close" data-dismiss="modal">×</button>	    			
	    			<h3>Авторизация</h3>
	  			</div>
	  			<div class="modal-body">
	  				<span id="tel-header-form">
		    			<input type="text" id="modal-login" name="tel-login" onkeyup="checkParams()" placeholder="Введите логин" required="">
		    			<input type="text" id="modal-pass" name="tel-pass" onkeyup="checkParams()" placeholder="Введите пароль" required="">
		    			<button type="submit" id="button-header-form" class="disabled">Отправить</button>
		    		</span>	
		    		<div class="modal-links clearfix">
		    			<a href="#" class="reg">Регистрация</a>
		    			<a href="#" class="pass">Забыли пароль?</a>
		    		</div>
	  			</div>	  			
	  		</div>
		</div>
	<!-- Yandex.Metrika counter -->
	<script type="text/javascript">
	    (function (d, w, c) {
	        (w[c] = w[c] || []).push(function() {
	            try {
	                w.yaCounter44141314 = new Ya.Metrika({
	                    id:44141314,
	                    clickmap:true,
	                    trackLinks:true,
	                    accurateTrackBounce:true
	                });
	            } catch(e) { }
	        });
	        var n = d.getElementsByTagName("script")[0],
	            s = d.createElement("script"),
	            f = function () { n.parentNode.insertBefore(s, n); };
	        s.type = "text/javascript";
	        s.async = true;
	        s.src = "https://mc.yandex.ru/metrika/watch.js";
	        if (w.opera == "[object Opera]") {
	            d.addEventListener("DOMContentLoaded", f, false);
	        } else { f(); }
	    })(document, window, "yandex_metrika_callbacks");
	</script>
	<noscript><div><img src="https://mc.yandex.ru/watch/44141314" style="position:absolute; left:-9999px;" alt="" /></div></noscript>
	<!-- /Yandex.Metrika counter -->
	</body>
</html>